Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Anaemia | 11% - 32% | x | |
| Nausea | 1% - 42% | x | |
| Fatigue | 5% - 37% | x | |
| Body temperature increased | 2% - 35% | x | |
| Vomiting | 1% - 29% | x | |
| Dyspnoea | 6% - 22% | x | |
| Diarrhoea | 2% - 23% | x | |
| Constipation | 1% - 23% | x | |
| Thrombocytopenia | 7% - 16% | x | |
| Rash | 1% - 20% | x | |
| Oedema peripheral | 0% - 20% | x | |
| Cough | 0% - 19% | x | |
| Pruritus | 3% - 16% | x | |
| Hyperlactacidaemia | 2% - 16% | x | |
| Chills | 1% - 16% | x | |
| Decreased appetite | 2% - 15% | x | |
| Hypokalaemia | 4% - 12% | x | |
| Headache | 0% - 15% | x | |
| Electrocardiogram QT prolonged | 4% - 11% | x | |
| Infusion site pain | 0% - 14% | x | |
| Hypotension | 3% - 10% | x | |
| Abdominal pain | 1% - 11% | x | |
| Phlebitis | 1% - 10% | x | |
| Dizziness | 0% - 10% | x | |
| Neoplasm malignant | x | ||
| Infection | x | ||
| Multi-organ failure | x | ||
| Pneumonia | x | ||
| Tumour lysis syndrome | x | ||
| Ventricular fibrillation | x | ||
| Hepatic failure | x | ||
| Creatinine increased | x | ||
| Hepatotoxicity | x | ||
| Febrile neutropenia | x | ||
| Electrocardiogram QT corrected interval prolonged | x | ||
| Gastrointestinal toxicity | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |